Literature DB >> 2731576

Autocrine regulation of bovine retinal capillary endothelial cell (BREC) proliferation by BREC-derived basic fibroblast growth factor.

M Bensaid1, F Malecaze, H Prats, F Bayard, J P Tauber.   

Abstract

Fibroblast growth factors (FGFs) are mitogenic for bovine retinal capillary endothelial cells (BREC) seeded at a low density. Seeding BREC cells at a high density greatly reduces their requirement for basic FGF (bFGF) in order to proliferate actively. We show here that monolayers of BREC cells synthesize and release into the culture medium a growth factor, which on the basis of biological activity, heparin affinity, immuno-cross reactivity with anti-bFGF antibodies and mRNA analysis, has been identified as basic fibroblast growth factor. These data indicate that BREC cells are able to synthesize and release bFGF, which can act as a promoting-growth factor for these cells by a para- and/or autocrine mechanism. We suggest thus, that this para- and/or autocrine mechanism involving bFGF may play a key role in preretinal neovascularization, particularly in diabetic patients presenting a proliferative retinopathy.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2731576     DOI: 10.1016/0014-4835(89)90065-1

Source DB:  PubMed          Journal:  Exp Eye Res        ISSN: 0014-4835            Impact factor:   3.467


  9 in total

1.  Characterization of release of basic fibroblast growth factor from bovine retinal endothelial cells in monolayer cultures.

Authors:  R A Brooks; J M Burrin; E M Kohner
Journal:  Biochem J       Date:  1991-05-15       Impact factor: 3.857

2.  Basic fibroblast growth factor is neither necessary nor sufficient for the development of retinal neovascularization.

Authors:  H Ozaki; N Okamoto; S Ortega; M Chang; K Ozaki; S Sadda; M A Vinores; N Derevjanik; D J Zack; C Basilico; P A Campochiaro
Journal:  Am J Pathol       Date:  1998-09       Impact factor: 4.307

Review 3.  The role of endothelium in the pathogenesis of diabetic microangiopathy.

Authors:  M La Selva; E Beltramo; P Passera; M Porta; G M Molinatti
Journal:  Acta Diabetol       Date:  1993       Impact factor: 4.280

4.  Poly (lactic-co-glycolic acid) as a controlled release delivery device.

Authors:  Tee Yong Lim; Chye Khoon Poh; W Wang
Journal:  J Mater Sci Mater Med       Date:  2009-03-13       Impact factor: 3.896

5.  cis-acting elements involved in the alternative translation initiation process of human basic fibroblast growth factor mRNA.

Authors:  A C Prats; S Vagner; H Prats; F Amalric
Journal:  Mol Cell Biol       Date:  1992-10       Impact factor: 4.272

6.  A new 34-kilodalton isoform of human fibroblast growth factor 2 is cap dependently synthesized by using a non-AUG start codon and behaves as a survival factor.

Authors:  E Arnaud; C Touriol; C Boutonnet; M C Gensac; S Vagner; H Prats; A C Prats
Journal:  Mol Cell Biol       Date:  1999-01       Impact factor: 4.272

7.  Alternative translation of human fibroblast growth factor 2 mRNA occurs by internal entry of ribosomes.

Authors:  S Vagner; M C Gensac; A Maret; F Bayard; F Amalric; H Prats; A C Prats
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

8.  Vitreoretinal toxicity of basic fibroblast growth factor.

Authors:  H Borhani; G A Peyman; M H Rahimy; R W Beuerman
Journal:  Int Ophthalmol       Date:  1993-08       Impact factor: 2.031

9.  Translation of CUG- but not AUG-initiated forms of human fibroblast growth factor 2 is activated in transformed and stressed cells.

Authors:  S Vagner; C Touriol; B Galy; S Audigier; M C Gensac; F Amalric; F Bayard; H Prats; A C Prats
Journal:  J Cell Biol       Date:  1996-12       Impact factor: 10.539

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.